Japan's approval of the world’s first medical treatments using reprogrammed human cells signals a new era in regenerative ...
Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...
Japan approves world-first iPS cell therapies for heart failure, Parkinsons Conditional approvals speed Japans first iPS treatments into clinics for heart failure and Parkinsons ...
On 6 March 2026, Japan approved the world’s first iPS stem cell treatments for Parkinson’s and severe heart failure. Could ...
Researchers in Japan pioneered reprogrammed cells 20 years ago. Now the country has given the first-ever authorizations to manufacture and sell medical products based on the technology.
The arterial vasculature is the second most frequently calcified structure in the human body after the skeleton. Calcification of the aorta and aortic valves occurs in most individuals in westernized ...